Money and Medicine The Build Back Better Act’s drug inflation rebate provision would reduce premiums by $3 billion (0.4%) in 2023 and $21 billion (1.7%) in 2031. (Photo: Shutterstock)

A new analysis estimates that introducing inflation rebates on most prescription drugs — a provision of the Build Back Better Act, which was passed in November by the U.S. House of Representatives — would lower employers’ health insurance premiums by $111 billion over the next decade.

Researchers at the nonprofit Urban Institute said that “limiting annual increases in drug prices through inflation rebates improves access to regular care and affordability, while generating billions of dollars in savings for the federal government and private insurers.”

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.